Related Experiment Video
Updated: Jun 16, 2026
14:04
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
24.8K
Methicillin resistant staphylococci isolated in clinical samples: a 3-year retrospective study analysis
Abdel Karim Foloum1, Luria Leslie Founou2,3,4, Sabrina Karang1
1Department of Biological Sciences, Higher Institute of Medical Technology, Yaoundé, Cameroon.
Future Science OA
|April 5, 2021
Summary
Methicillin-resistant staphylococci (MRS) are prevalent in clinical samples in Yaoundé, Cameroon, with methicillin-resistant Staphylococcus aureus (MRSA) being common. Antimicrobial resistance surveillance and stewardship are crucial.
Area of Science:
- Clinical microbiology
- Infectious diseases
- Antimicrobial resistance
Background:
- Methicillin-resistant staphylococci (MRS) pose a significant global health threat.
- Understanding local resistance patterns is vital for effective treatment and control.
Purpose of the Study:
- To determine the prevalence of MRS in clinical specimens.
- To describe antimicrobial resistance patterns of MRS in Yaoundé, Cameroon.
- To establish a baseline for future surveillance efforts.
Main Methods:
- Analysis of 1683 clinical samples collected between January 2017 and December 2019.
- Bacterial identification and antibiotic susceptibility testing.
- Statistical analysis using R program.
Main Results:
- Staphylococci were identified in 5.35% of samples.
- MRS accounted for 83.33% of staphylococcal isolates.
- Methicillin-resistant Staphylococcus aureus (MRSA) comprised 78.67% of MRS isolates.
- MRS infection prevalence increased with age.
Conclusions:
- The study provides essential baseline data on MRS prevalence and resistance in Yaoundé.
- Highlights the urgent need for enhanced antimicrobial stewardship and infection control programs.
- Supports the development of targeted interventions to combat antimicrobial resistance.
Related Concept Videos
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...